TADALAFIL TEVA 10 mg, film-coated tablet 4 tablets, CIP 3400930094297
Active ingredients: Tadalafil
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet4 tablets, CIP 3400930094297orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TADALAFIL TEVA 10 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 1 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62350491CIP73009429CIP133400930094297Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TADALAFILcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.